ReviewMolecular neurobiology2026
Roles of Folate-Dependent Epigenetic Modifications in Major Depressive Disorder.
Review in Molecular neurobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Major depressive disorder (MDD) is a complex psychiatric condition that affects over 280 million individuals globally. MDD etiology remains undefined; however, recent research demonstrates a significant link between epigenetics and its underlying molecular mechanisms. Epigenetic modifications such as DNA and histone methylation require methyl groups, with S-adenosylmethionine (SAM) serving as the methyl-group donor generated through one-carbon metabolism. Folate plays a crucial role in regulating one-carbon metabolism, facilitating the conversion of methionine to SAM. MDD is increasingly associated with altered folate status, one-carbon metabolism, and epigenetic regulation in depression, although the extent to which these mechanisms contribute to MDD remains incompletely understood. This review consolidates evidence linking folate biology to epigenetic mechanisms in MDD, integrating findings from human observational and clinical studies with evidence from cellular and animal models. Overall, current evidence supports a biologically plausible connection between folate-dependent one-carbon metabolism and epigenetic regulation in MDD, while highlighting the need for further mechanistic and clinical studies to clarify these relationships and determine their potential therapeutic relevance.
Indexed as
Identifiers
42965784What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.